Last reviewed · How we verify
Recombinant human growth hormone - Hormotrop
Recombinant human growth hormone - Hormotrop is a Small molecule drug developed by Ache Laboratorios Farmaceuticos S.A.. It is currently FDA-approved.
At a glance
| Generic name | Recombinant human growth hormone - Hormotrop |
|---|---|
| Sponsor | Ache Laboratorios Farmaceuticos S.A. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Recombinant human growth hormone - Hormotrop CI brief — competitive landscape report
- Recombinant human growth hormone - Hormotrop updates RSS · CI watch RSS
- Ache Laboratorios Farmaceuticos S.A. portfolio CI
Frequently asked questions about Recombinant human growth hormone - Hormotrop
What is Recombinant human growth hormone - Hormotrop?
Recombinant human growth hormone - Hormotrop is a Small molecule drug developed by Ache Laboratorios Farmaceuticos S.A..
Who makes Recombinant human growth hormone - Hormotrop?
Recombinant human growth hormone - Hormotrop is developed and marketed by Ache Laboratorios Farmaceuticos S.A. (see full Ache Laboratorios Farmaceuticos S.A. pipeline at /company/ache-laboratorios-farmaceuticos-s-a).
What development phase is Recombinant human growth hormone - Hormotrop in?
Recombinant human growth hormone - Hormotrop is FDA-approved (marketed).